These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Off-label drug prescribing on a state university obstetric service. Rayburn WF; Turnbull GL J Reprod Med; 1995 Mar; 40(3):186-8. PubMed ID: 7776301 [TBL] [Abstract][Full Text] [Related]
4. Managing the risks of off-licence prescribing in pregnancy. Shah S; van Geijn H Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):156-9. PubMed ID: 17046143 [TBL] [Abstract][Full Text] [Related]
5. Uses of drugs not described in the package insert (off-label uses). Committee on Drugs. American Academy of Pediatrics Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968 [TBL] [Abstract][Full Text] [Related]
6. Drug, patient, and physician characteristics associated with off-label prescribing in primary care. Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695 [TBL] [Abstract][Full Text] [Related]
7. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs. Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390 [TBL] [Abstract][Full Text] [Related]
8. Satisfaction with pharmacotherapy for approved and off-label indications--a Delphi study. Kos M; Wertheimer AI; Mrhar A Ann Pharmacother; 2005 Apr; 39(4):649-54. PubMed ID: 15755789 [TBL] [Abstract][Full Text] [Related]
9. [Off-label prescribing]. Blondon K; Desmeules J; Vogt-Ferrier N; Besson M; Kondo-Oestreicher M; Dayer P Rev Med Suisse; 2008 Jul; 4(165):1661-5. PubMed ID: 18767292 [TBL] [Abstract][Full Text] [Related]
12. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use. Meadows WA; Hollowell BD Int J Impot Res; 2008; 20(2):135-44. PubMed ID: 18004389 [TBL] [Abstract][Full Text] [Related]
14. Enforcement related to off-label marketing and use of drugs and devices: where have we been and where are we going? Joseph JN; Deaton D; Ehsan H; Bonanno MA J Health Life Sci Law; 2009 Jan; 2(2):73-108. PubMed ID: 19288889 [TBL] [Abstract][Full Text] [Related]
15. Positive outcomes through the appropriate use of off-label prescribing. Bright JL Arch Intern Med; 2006 Dec 11-25; 166(22):2554-5; author reply 2555. PubMed ID: 17159026 [No Abstract] [Full Text] [Related]
17. Off-label use: an industry perspective on expanding use beyond approved indications. Russell ME; Friedman MI; Mascioli SR; Stolz LE J Interv Cardiol; 2006 Oct; 19(5):432-8. PubMed ID: 17020568 [TBL] [Abstract][Full Text] [Related]
18. Off-label use of prescription medication: nursing implications. Keltz JM Nephrol Nurs J; 2003 Feb; 30(1):99-100. PubMed ID: 12674960 [TBL] [Abstract][Full Text] [Related]
19. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women's Hospital. Herring C; McManus A; Weeks A Int J Pharm Pract; 2010 Aug; 18(4):226-9. PubMed ID: 20636674 [TBL] [Abstract][Full Text] [Related]
20. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription. Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]